How ERDERA addresses PPIE

ERDERA embeds Public and Patient Involvement and Engagement (PPIE) as a core, cross-cutting function within its governance and all work packages, ensuring that people living with rare diseases are involved as co-designers, implementers, and evaluators of research

In practice, this is operationalised through a dedicated PPIE group that:

Acts as the central coordination hub for patient involvement across the programme

Monitors work packages and works with their leaders to embed meaningful patient participation

Identifies where and how patients can contribute across the research lifecycle (design, calls, governance, dissemination)

Supports onboarding and capacity-building of patient advocates

Ensures research priorities, communication, training, and national alignment activities remain patient-centred

Overall, PPIE in ERDERA is not a standalone activity but a system-wide approach integrated into governance, funding processes, and research implementation.

Who leads and drives PPIE

blank

EURORDIS

blank

AFM-Téléthon

blank

World Duchenne
Organisation

blank

Rare Diseases
International

blank

Health Research
Charities Ireland

blank

Genetic Alliance
UK

These partners form a multi-organisation patient-led group that meets regularly and acts as the focal point for patient engagement across ERDERA.

International perspective

Funders such as the National Institute for Health and Care Research (NIHR), the Health Research Board (HRB) in Ireland, the Canadian Institutes of Health Research (CIHR) and the National Institutes of Health (NIH) increasingly expect meaningful PPIE in funded projects.

Across these systems, the shared goal is co-production of research with those it is intended to benefit.

Key takeaway

ERDERA operationalises PPIE through a dedicated, patient-led coordination group embedded in governance, ensuring that patient perspectives systematically shape strategy, research design, funding, and implementation across the entire partnership.

Resources related to PPIE are available within the Learning Portal and can be accessed by applying the relevant filters.

You might also be interested in

Young rare disease advocates strengthen their role in research at ERDERA training in Paris

Young advocates met in Paris from 23–25 April 2026 for the second ERDERA Training for Young Advocates for Rare Diseases, focused on advocacy, clinical research, patient rights and partnership in paediatric rare disease research.

Advancement of Treatments for Rare Diseases

The two-day event will focus on translating research and policy initiatives into tangible benefits for Rare Disease patients through better prevention, diagnosis, and treatment.

Women’s Day highlights widening gender inequalities in rare diseases

Drawing on Europe-wide patient and carer surveys, ERDERA highlights how gender can shape diagnostic delays, care burden and the evidence base for rare-disease research.

EURORDIS Black Pearl Awards 2026: celebrating rare disease champions in Brussels and online

On 24 February, in Brussels and online, EURORDIS will bring the rare disease community together for its fifteenth Black Pearl Awards ceremony, held in the lead‑up to Rare Disease Day.

Courses

blank

Open Academy x ERDERA Schools

Hybrid Open Academy x ERDERA training equipping rare disease advocates and early‑career researchers to navigate health data, ethics and AI in European rare disease research.
e-learning
intermediate
blank

2nd ERDERA Training for Young Advocates for Rare Diseases

This training aims to empower young patients by providing them with the knowledge, confidence and skills needed to actively take part in paediatric and rare disease research.
workshop
basic
blank

Management of multinational clinical trials for rare diseases

Practical online course on planning and managing multinational clinical trials across Europe, including regulatory/ethics, roles, budgets, and patient engagement.
e-learning
basic
blank

Closed training

Materials available

blank

Enhancing Patient-Centricity in Rare Disease Clinical Trials

Don’t miss this opportunity to share your expertise and help shape the future of clinical research in ultra-rare conditions!
webinar
intermediate